News tagged with drug regimens

Triple drug combination is promising option to treat metastatic HER2+ breast cancer

Combining two chemotherapy drugs with trastuzumab (Herceptin) to treat women who have metastatic HER2+ breast cancer may offer physicians another choice in their treatment options.

Medicine & Health / Cancer

created May 15, 2009 | popularity 5 / 5 (1) | comments 0